Hematology TimesLarge MM trial finds denosumab non-inferior to ZA for SREJune 19, 2017Multiple Myeloma
Hematology TimesCompany pauses enrollment on 2 trials of pembrolizumab in MMJune 14, 2017Multiple MyelomaPharmacy
Hematology TimesCombo with daratumumab could be alternative to ASCT in MMJune 13, 2017Multiple MyelomaTransplantation
Hematology NewsNovel CAR T cells drive high objective response rate in multiple myelomaJune 12, 2017Lymphoma & Plasma Cell DisordersMultiple Myeloma
Oncology PracticeFDA panel backs licensure for epoetin alfa biosimilarMay 26, 2017Patient & Survivor CareAnemiaMultiple Myeloma
Hematology TimesWhy fewer blood cancer patients receive hospice careMay 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAggressive Lymphomas
Hematology NewsSmoldering myeloma progressed more rapidly in patients with elevated BMIsMay 19, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsMyeloma patients who get solid tumor cancers do as well as other cancer patientsMay 19, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsLenalidomide maintenance boosted depth of response in myeloma patientsMay 19, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesCompound could treat lymphoma, myelomaMay 17, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesStudy: Most oncologists don’t discuss exercise with patientsMay 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
